• SPONSOR:  Maze Therapeutics 

• INDICATION:  Chronic Kidney Disease 

• STUDY:  MZE829-201:  An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype 

• LOCATION: GEORGIA

• SPONSOR:  Coologics, Inc. 

• INDICATION:  Vulvovaginal Candidiasis (VVC) 

• STUDY:  Open-label, Uncontrolled Clinical Research Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC) 

• LOCATION: GEORGIA

​

​

​

• SPONSOR:  Merck Sharp & Dohme LLC

• INDICATION: COVID-19

• STUDY: 023-02:

• A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression

• LOCATION: GEORGIA

• SPONSOR:  Apple, Inc

• INDICATION: prospective, virtual, non-significant risk study to Collect data to characterize two different sensor configurations in smartwatches

• LOCATION: Anywhere in the uS